TrialMemorias do Instituto Oswaldo Cruz2024

Homologous equivalence study of immunogenicity after third dose of Covid-19 vaccine (recombinant) with an interval of six months after the second dose, comparing the interval of eight and 12 weeks between the first two doses.

Clarice Monteiro Vianna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.